Australia has been an important partner in international cancer research as part of the Cancer Moonshot since 2016. This international cancer moonshot collaboration brings together the scientific and technical capabilities of Macquarie University, Children's Medical Research Institute, Garvan Institute of Medical Research, and Bioplatforms Australia.

Team Australia’s work under NCI’s ICPC has focused on melanoma skin cancer, colorectal cancer, childhood and young onset cancers, and rare and neglected cancers.

Recently, this team completed a protein map for 949 cancer cell lines across over 40 cancer types, which have been tested with 650 different treatments (published in Cancer Cell, 2022). Advanced computational methods were then used to predict the response of cancer cells to treatment. This study lays the foundation for ongoing efforts to predict the response of individual cancer to drugs based on the proteins cancer contains.

Read more about the NCI Moonshot partnership here.